Niraparib Tosylate Hydrate

Our enterprise since its inception, constantly regards product good quality as organization life, constantly improve production technology, strengthen merchandise high quality and continuously strengthen enterprise total good quality administration, in strict accordance with all the national standard ISO 9001:2000 for Niraparib Tosylate Hydrate, Lyrica Pregabalina, Ramipril And Hydrochlorothiazide, Doxycycline Hyclate For Bv, Our enterprise insists on innovation to promote the sustainable advancement of organization, and make us become the domestic high-quality suppliers. We've been committed to offering easy,time-saving and money-saving one-stop purchasing support of consumer for Niraparib Tosylate Hydrate, To create more creative products, maintain high-quality products and update not only our products but ourselves so as to keep us ahead of the world, and the last but most vital one: to make every client satisfied with everything we offer and to grow stronger together. To be the real winner, starts here!


  • Niraparib 1038915-60-4

    Niraparib 1038915-60-4

    API’s Name Indication Innovator Patent Expiry Date(The U.S)
    Niraparib 1038915-60-4 Ovarian/Fallopian,tube/primary  peritoneal cancer Tesaro Jan.8, 2028
  • Lowest Price for Doxycycline Monohydrate Treats - Enalapril Maleate  – CPF

    Lowest Price for Doxycycline Monohydrate Treats - Enalapril Maleate – CPF

    Background Enalapril Maleate Description Enalapril (maleate) (MK-421 (maleate)), the active metabolite of enalapril, is an angiotensin-converting enzyme (ACE) inhibitor. In Vivo Enalapril (MK-421) is a prodrug that belongs to the angiotensin-converting enzyme (ACE) inhibitor class of medications. It is rapidly metabolized in the liver to enalaprilat following oral administration. Enalapril (MK-421) is a potent, competitive inhibitor of ACE, the enzyme responsible for the conversion of angio...
  • High reputation Doxycycline Monohydrate 100 Mg Oral Capsule - Thalidomide  – CPF

    High reputation Doxycycline Monohydrate 100 Mg Oral Capsule - Thalidomide – CPF

    Background Thalidomide was introduced as a sedative drug,immunomodulatory agent and also is investigated for treating symptoms of many cancers.Thalidomide inhibits an E3 ubiquitin ligase, which is a CRBN-DDB1-Cul4A complex. Description Thalidomide is initially promoted as a sedative, inhibits cereblon (CRBN), a part of the cullin-4 E3 ubiquitin ligase complex CUL4-RBX1-DDB1, with a Kd of ∼250 nM, and has immunomodulatory, anti-inflammatory and anti-angiogenic cancer properties. In Vitro Tha...
  • Europe style for Doxycycline Hyclate 50 Mg Cap - Baloxavir Marboxil 1985606-14-1  – CPF

    Europe style for Doxycycline Hyclate 50 Mg Cap - Baloxavir Marboxil 1985606-14-1 – CPF

    Background Baloxavir marboxil is an antiviral drug and is an endonuclease inhibitor. In rats and monkeys, the blood concentration of the drug is lower than the minimum detection amount in a single oral administration of the drug. In preclinical influenza A and B infection models (including strains that are resistant to existing antiviral drugs), Baloxavir marboxil has a certain effect. Chemical Properties Storage Store at -20°C M.Wt 571.55 Cas No. 1985606-14-1 Formula C27H23F2N3O7S ...
  • Good quality Daclatasvir - Baloxavir Marboxil 1985606-14-1  – CPF

    Good quality Daclatasvir - Baloxavir Marboxil 1985606-14-1 – CPF

    Background Baloxavir marboxil is an antiviral drug and is an endonuclease inhibitor. In rats and monkeys, the blood concentration of the drug is lower than the minimum detection amount in a single oral administration of the drug. In preclinical influenza A and B infection models (including strains that are resistant to existing antiviral drugs), Baloxavir marboxil has a certain effect. Chemical Properties Storage Store at -20°C M.Wt 571.55 Cas No. 1985606-14-1 Formula C27H23F2N3O7S ...
  • 2020 New Style Hydrochlorothiazide 50mg - Niraparib 1038915-60-4  – CPF

    2020 New Style Hydrochlorothiazide 50mg - Niraparib 1038915-60-4 – CPF

    Description Niraparib (MK-4827) is a highly potent and orally bioavailable PARP1 and PARP2 inhibitor with IC50s of 3.8 and 2.1 nM, respectively. Niraparib leads to inhibition of repair of DNA damage, activates apoptosis and shows anti-tumor activity.   In Vitro Niraparib (MK-4827) inhibits PARP activity with EC50=4 nM and EC90=45 nM in a whole cell assay. MK-4827 inhibits proliferation of cancer cells with mutant BRCA-1 and BRCA-2 with CC50 in the 10-100 nM range. MK-4827 displays exce...
  • Factory Cheap Hydrochlorothiazide Generic - Bictegravir 1611493-60-7  – CPF

    Factory Cheap Hydrochlorothiazide Generic - Bictegravir 1611493-60-7 – CPF

    Description Bictegravir is a novel, potent inhibitor of HIV-1 integrase with an IC50 of 7.5 nM. In Vitro Bictegravir (BIC) inhibits the strand transfer activity with an IC50 of 7.5± 0.3 nM. Relative to its inhibition of strand transfer activity, Bictegravir is a much weaker inhibitor of 3′-processing activity of HIV-1 IN, with an IC50 of 241±51 nM. Bictegravir enhances the accumulation of 2-LTR circles ~5-fold relative to the mock-treated control and reduces the amount of authentic integrati...
  • OEM manufacturer Doxycycline Monohydrate For Pneumonia - LOXO-101 1223403-58-4  – CPF

    OEM manufacturer Doxycycline Monohydrate For Pneumonia - LOXO-101 1223403-58-4 – CPF

    Background IC50: low nanomolar range for inhibition of all TRK family members LOXO-101 is a tropomyosin receptor kinases (TRK) inhibitor. The TRK family of neurotrophin receptors and their neurotrophin ligands regulate neuron growth, differentiation and survival. In vitro: In previous study, LOXO-101 was evaluated for off-target kinase enzyme inhibition against a panel of non-TRK kinases at a concentration of 1,000 nM and ATP concentrations around the Km. Results showed that LOXO-101 had grea...
  • Short Lead Time for Venetoclax Supplier - Ezetimibe  – CPF

    Short Lead Time for Venetoclax Supplier - Ezetimibe – CPF

    Background Ezetimibe is a potent and novel inhibitor of cholesterol absorption [1]. Cholesterol is a lipid molecule and is required to build and maintain membranes structural integrity and fluidity. Also, it serves as a precursor of vitamin D, bile acids and steroid hormones. In differentiated Caco-2 cells incubated with a carotenoid (1 μM), ezetimibe (10 mg/L) inhibited carotenoid transport with 50% inhibition for ɑ-carotene and β-carotene. Also, it inhibited the transport of β-cryptoxanthin...
  • OEM Manufacturer Doxycycline Hyclate 100mg Español - Tofacitnib Citrate  – CPF

    OEM Manufacturer Doxycycline Hyclate 100mg Español - Tofacitnib Citrate – CPF

    Background Tofacitinib citrate, also known as CP-690550 citrate, is a potent inhibitor of janus kinase 3 (JAK3), a hematopoetic cell-restricted tyrosine kinase involved in signal transduction regulating lymphocyte survival, proliferation, differentiation, and apoptosis.  The inhibition is JAK3 specific with a selectivity 1000-fold more than other non-JAK family kinases. Besides inhibiting JAKS (IC50 = 1 nM), tofacitinib citrate also inhibits janus kinase 2 (JAK2) and janus kinase 1 (JAK1) wit...
  • 100% Original Factory Sofosbuvir - Sugammadex Sodium  – CPF

    100% Original Factory Sofosbuvir - Sugammadex Sodium – CPF

    舒更葡糖钠 Sugammadex Sodium 343306-79-6 In-House Description Sugammadex sodium is a synthetic γ-cyclodextrin derivative, and acts as a new reversal agent for neuromuscular block. Generic Name: sugammadex (soo GAM ma dex) Brand Name: Bridion Sugammadex reverses the effects of certain medications that are given during surgical procedures to relax your muscles. Sugammadex is used at the end of surgery, to help restore muscle function that has been blocked during surgery by the other ...
  • China Wholesale Rosuvastatin Calcium Use Factory - Folic Acid  – CPF

    China Wholesale Rosuvastatin Calcium Use Factory - Folic Acid – CPF

    Background Extracted from Spinacia oleracea;Store the product in sealed, cool and dry condition Description Folic acid(Vitamin M; Vitamin B9) is a B vitamin; is necessary for the production and maintenance of new cells, for DNA synthesis and RNA synthesis. Clinical Trial NCT Number Sponsor Condition Start Date Phase NCT03332602 Swiss Federal Institute of Technology Iron-deficiency April 4, 2018 Not Applicable Storage 4°C, protect from light *In solvent : -80°C, 6 months; -20°C, ...